FDA Ethics Act of 2022
Official title: To address potential conflicts of interest among entities serving as Food and Drug Administration contractors, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
FDA Ethics Act of 2022
This bill establishes several requirements for entities that contract with the Food and Drug Administration (FDA) relating to conflicts of interest, including requiring contractors to disclose conflicts of interest on an ongoing basis and prohibiting the FDA from hiring consultants who simultaneously provide services to drug manufacturers or other entities that are regulated by the FDA.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 8828: FDA Ethics Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-HR-8828/
"H.R. 8828: FDA Ethics Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-8828/.
H.R. 8828, 117th Cong. (2026), https://openamerica.io/bill/117-HR-8828/.
[H.R. 8828: FDA Ethics Act of 2022](https://openamerica.io/bill/117-HR-8828/)